AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 750.00 Change Price %
High 754.95 1 Day -3.40 -0.45
Low 737.95 1 Week -14.45 -1.90
Close 745.55 1 Month 40.80 5.79
Volume 1661421 1 Year -60.40 -7.49
52 Week High 895.00
52 Week Low 503.05
AUROPHARMA Important Levels
Resistance 2 761.31
Resistance 1 754.82
Pivot 746.15
Support 1 736.29
Support 2 729.79
NSE INDIA Most Active Stocks
JPASSOCIAT 18.55 5.10%
SOUTHBANK 31.45 8.26%
UNITECH 7.35 5.00%
IDEA 80.15 -3.67%
RCOM 19.75 -1.74%
ADANIPOWER 32.35 2.05%
DIVISLAB 942.80 9.22%
SUZLON 16.75 0.00%
HUDCO 89.45 1.36%
BOMDYEING 202.80 4.89%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
PANORAMUNI 9.60 20.00%
VIVIMEDLAB 138.20 19.97%
INDOTECH 256.60 19.24%
NAKODA 0.35 16.67%
ITDC 580.50 16.65%
HIRECT 143.25 15.57%
GSCLCEMENT 38.40 14.12%
DAMODARIND 109.80 13.96%
WALCHANNAG 231.50 13.96%
More..
NSE INDIA Top Losers Stocks
PRAKASHCON 4.55 -7.14%
PREMIERPOL 36.65 -6.51%
DQE 18.35 -6.38%
INTENTECH 87.35 -6.33%
PRATIBHA 10.00 -6.10%
SWANENERGY 148.25 -5.81%
TAKE 158.95 -5.72%
COMPUSOFT 14.10 -5.69%
SYNCOM 5.05 -5.61%
LITL 0.85 -5.56%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 3
As on 20th Sep 2017 AUROPHARMA Share Price closed @ 745.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 689.63 & Buy for SHORT-TERM with Stoploss of 727.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for September
1st Target up-side 771.79
2nd Target up-side 804.42
3rd Target up-side 837.04
1st Target down-side 678.71
2nd Target down-side 646.08
3rd Target down-side 613.46
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 52.84 Sideways
MFI (14) MFI is 60.43 Sideways
CCI (20) CCI is 9.39 Sideways
WILLIAM %R (14) William %R is -56.60 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 776.00
10 Day Avg Volume Traded -19.51 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.